Invitrogen and Applied Biosystems to Become Life Technologies
The European Commission stated that its investigation had focused on nucleic acid amplification and concluded that customers would still have a choice of other suppliers. The three new Board members currently sit on Applied Biosystems’ Board. Life Technologies’ shares will trade on the NASDAQ stock exchange under the symbol LIFE.
Carlsbad, CA 11/4/08; Carlsbad, CA and Norwalk, CT 11/11/08—Invitrogen and Applied Biosystems’ merger has received clearance from the European Commission (see IBO 6/15/08). As a result, the companies are expected to complete the transaction on November 21. Invitrogen has also announced that the company will be renamed Life Technologies. Instruments and systems will continue to be sold under the Applied Biosystems name and the companies’ reagents will be sold under the Invitrogen name. The three new members of the new company’s Board of Directors were also named. They are George F. Adam, Jr., chairman of Recondo Technology; Arnold J. Levine, Ph.D., professor at the Institute for Advanced Study; and William H. Longfield, retired chairman and CEO of C.R. Bard.
